SCHEMBL28534476

SCHEMBL28534476

CCOC(=O)C1(OC(=O)c2ccccc2C)CCC(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 3/20 0.39
OPRM1 P35372 5/20 0.39
KCNA3 P22001 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CCR6 P51684 1/20 0.38
OPRD1 P41143 3/20 0.38
OPRK1 P41145 3/20 0.38
SLC22A1 O15245 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529036 0.88 DDB1 (0.44) TSHRKMT2AMEN1ALDH1A1RAB9A
SCHEMBL28533037 0.79 CCR6 (0.33) TSHRKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL18789282 0.73 ATM (0.41) KMT2AMEN1SMN1; SMN2MAPTOPRM1
SCHEMBL1569293 0.72 TSHR (0.80) TSHRKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL29535471 0.72 TSHR (0.80) TSHRKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL27501881 0.70 TSHR (0.77) TSHRKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL3536978 0.70 OPRM1 (0.69) OPRM1KCNA3OPRD1OPRK1SLC22A1
SCHEMBL12362140 0.69 MEN1 (0.35) KMT2AMEN1SMN1; SMN2ALDH1A1GAA
SCHEMBL19766 0.69 POLB (0.42) TSHRKMT2AMEN1SMN1; SMN2MAPT
SCHEMBL15967719 0.68 DDB1 (0.50) KMT2AALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153700-B C-3 and C-17 modified triterpenoids as HIV-1 inhibitors VIIV保健英国第五有限公司 2021-03-09 CN disclosed